Frank Stegmeier

16.4k total citations · 2 hit papers
34 papers, 4.7k citations indexed

About

Frank Stegmeier is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Frank Stegmeier has authored 34 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Frank Stegmeier's work include CRISPR and Genetic Engineering (10 papers), Microtubule and mitosis dynamics (8 papers) and DNA Repair Mechanisms (5 papers). Frank Stegmeier is often cited by papers focused on CRISPR and Genetic Engineering (10 papers), Microtubule and mitosis dynamics (8 papers) and DNA Repair Mechanisms (5 papers). Frank Stegmeier collaborates with scholars based in United States, Switzerland and China. Frank Stegmeier's co-authors include Angelika Amon, Stephen J. Elledge, William R. Sellers, Rosella Visintin, Gregory J. Hannon, Alice Loo, Richard J. Rickles, Guang Hu, Susan Wee and Christoph Lengauer and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Frank Stegmeier

33 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantitative Proteomics of the Cancer Cell Line Encyclopedia

2020 574 citations Gregory V. Kryukov, Frank Stegmeier et al. Cell profile →
An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)

2013 425 citations Manav Korpal, Joshua M. Korn et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Stegmeier United States	23	3.7k	1.2k	888	702	666	34	4.7k
Ilya G. Serebriiskii United States	33	2.5k 0.7×	730 0.6×	1.0k 1.1×	488 0.7×	346 0.5×	97	3.8k
Wen-Lin Kuo United States	22	3.4k 0.9×	1.4k 1.1×	1.4k 1.6×	987 1.4×	278 0.4×	30	4.7k
Pengbo Zhou United States	37	3.4k 0.9×	787 0.6×	1.1k 1.2×	414 0.6×	341 0.5×	68	4.4k
Eva Petermann United Kingdom	33	5.5k 1.5×	838 0.7×	2.7k 3.0×	982 1.4×	265 0.4×	47	6.2k
Gopal P. Sapkota United Kingdom	33	3.9k 1.0×	790 0.6×	1.1k 1.2×	503 0.7×	239 0.4×	67	4.8k
Brian Gabrielli Australia	47	4.6k 1.2×	1.6k 1.3×	2.1k 2.4×	887 1.3×	287 0.4×	129	6.0k
Ron Firestein United States	35	2.9k 0.8×	516 0.4×	1.2k 1.4×	679 1.0×	358 0.5×	59	4.3k
Per Hydbring Sweden	20	3.6k 1.0×	754 0.6×	1.5k 1.6×	708 1.0×	604 0.9×	38	5.0k
Claus Storgaard Sørensen Denmark	40	5.3k 1.4×	1.4k 1.2×	2.4k 2.7×	839 1.2×	226 0.3×	65	6.0k
Jill M. Lahti United States	46	4.3k 1.1×	877 0.7×	1.8k 2.1×	926 1.3×	334 0.5×	88	5.9k

Countries citing papers authored by Frank Stegmeier

Since Specialization

Citations

This map shows the geographic impact of Frank Stegmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Stegmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Stegmeier more than expected).

Fields of papers citing papers by Frank Stegmeier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Stegmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Stegmeier. The network helps show where Frank Stegmeier may publish in the future.

Co-authorship network of co-authors of Frank Stegmeier

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Stegmeier. A scholar is included among the top collaborators of Frank Stegmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Stegmeier. Frank Stegmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tobin, Erica R., Pamela Sullivan, Hugh Gannon, et al.. (2023). Abstract 1581: KSQ-4279, a first-in-class USP1 inhibitor shows strong combination activity with multiple PARP inhibitors in BRCA mutant cancers. Cancer Research. 83(7_Supplement). 1581–1581. 2 indexed citations

Sullivan, Pamela, Yuji Mishina, Anne E. Dodson, et al.. (2023). Abstract 2771: KSQ-4279 mediated USP1 inhibition induces replication associated DNA gaps that contribute to cell death. Cancer Research. 83(7_Supplement). 2771–2771. 1 indexed citations

Kuiken, Hendrik J., Sabin Dhakal, Laura M. Selfors, et al.. (2021). Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contexts. Oncogene. 41(1). 112–124. 5 indexed citations

Shenker, Sol, Hugh Gannon, Paula Grasberger, et al.. (2021). Abstract 1337: Functional genomic characterization of the USP1 inhibitor KSQ-4279 reveals a distinct mechanism of action and resistance profile relative to other DDR targeting drugs. Cancer Research. 81(13_Supplement). 1337–1337. 7 indexed citations

Lantermann, Alexandra B., Dongshu Chen, Greg Hoffman, et al.. (2015). Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non–Small Cell Lung Cancer. Cancer Research. 75(22). 4937–4948. 43 indexed citations

Zhou, Qianhe, Adnan Derti, David A. Ruddy, et al.. (2015). A Chemical Genetics Approach for the Functional Assessment of Novel Cancer Genes. Cancer Research. 75(10). 1949–1958. 57 indexed citations

Huang, Franklin W., Craig M. Bielski, Mikael L. Rinne, et al.. (2015). TERT promoter mutations and monoallelic activation of TERT in cancer. Oncogenesis. 4(12). e176–e176. 72 indexed citations

Korpal, Manav, Joshua M. Korn, Xueliang Gao, et al.. (2013). An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide). Cancer Discovery. 3(9). 1030–1043. 425 indexed citations breakdown →

Naylor, Tara L., Huaping Tang, Boris A. Ratsch, et al.. (2011). Protein Kinase C Inhibitor Sotrastaurin Selectively Inhibits the Growth of CD79 Mutant Diffuse Large B-Cell Lymphomas. Cancer Research. 71(7). 2643–2653. 88 indexed citations

10.

Song, Eun Joo, Shannon L. Werner, Frank Stegmeier, et al.. (2010). The Prp19 complex and the Usp4^Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome. Genes & Development. 24(13). 1434–1447. 183 indexed citations

11.

Stegmeier, Frank, Markus Warmuth, William R. Sellers, & Marion Dorsch. (2010). Targeted Cancer Therapies in the Twenty-First Century: Lessons From Imatinib. Clinical Pharmacology & Therapeutics. 87(5). 543–552. 148 indexed citations

12.

Wee, Susan, Zainab Jagani, Kay X. Xiang, et al.. (2009). PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers. Cancer Research. 69(10). 4286–4293. 354 indexed citations

13.

Wee, Susan, Dmitri Wiederschain, Sauveur-Michel Maira, et al.. (2008). PTEN-deficient cancers depend on PIK3CB. Proceedings of the National Academy of Sciences. 105(35). 13057–13062. 411 indexed citations

14.

Stegmeier, Frank, Michael Rapé, Viji M. Draviam, et al.. (2007). Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature. 446(7138). 876–881. 301 indexed citations

15.

Ceol, Craig J., Frank Stegmeier, Melissa M. Harrison, & H. Robert Horvitz. (2006). Identification and Classification of Genes That Act Antagonistically to let-60 Ras Signaling in Caenorhabditis elegans Vulval Development. Genetics. 173(2). 709–726. 36 indexed citations

16.

Stegmeier, Frank, Guang Hu, Richard J. Rickles, Gregory J. Hannon, & Stephen J. Elledge. (2005). A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proceedings of the National Academy of Sciences. 102(37). 13212–13217. 437 indexed citations

17.

Stegmeier, Frank, et al.. (2004). The Replication Fork Block Protein Fob1 Functions as a Negative Regulator of the FEAR Network. Current Biology. 14(6). 467–480. 45 indexed citations

18.

D’Amours, Damien, Frank Stegmeier, & Angelika Amon. (2004). Cdc14 and Condensin Control the Dissolution of Cohesin-Independent Chromosome Linkages at Repeated DNA. Cell. 117(4). 455–469. 232 indexed citations

19.

Visintin, Rosella, Frank Stegmeier, & Angelika Amon. (2003). The Role of the Polo Kinase Cdc5 in Controlling Cdc14 Localization. Molecular Biology of the Cell. 14(11). 4486–4498. 78 indexed citations

20.

Stegmeier, Frank, Rosella Visintin, & Angelika Amon. (2002). Separase, Polo Kinase, the Kinetochore Protein Slk19, and Spo12 Function in a Network that Controls Cdc14 Localization during Early Anaphase. Cell. 108(2). 207–220. 351 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact